JPS4817267B1 - - Google Patents

Info

Publication number
JPS4817267B1
JPS4817267B1 JP45049666A JP4966670A JPS4817267B1 JP S4817267 B1 JPS4817267 B1 JP S4817267B1 JP 45049666 A JP45049666 A JP 45049666A JP 4966670 A JP4966670 A JP 4966670A JP S4817267 B1 JPS4817267 B1 JP S4817267B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP45049666A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP45049666A priority Critical patent/JPS4817267B1/ja
Priority to US145468A priority patent/US3867437A/en
Priority to NL7107358A priority patent/NL7107358A/xx
Priority to SE07336/71A priority patent/SE366542B/xx
Priority to GB1949271*[A priority patent/GB1320484A/en
Priority to CH857671A priority patent/CH555806A/xx
Priority to DE2128381A priority patent/DE2128381C3/de
Priority to FR7120913A priority patent/FR2095112A5/fr
Priority to BE768276A priority patent/BE768276A/xx
Publication of JPS4817267B1 publication Critical patent/JPS4817267B1/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C1/00—Ingredients generally applicable to manufacture of glasses, glazes, or vitreous enamels
    • C03C1/002—Use of waste materials, e.g. slags
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Materials Engineering (AREA)
  • Public Health (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
JP45049666A 1970-06-09 1970-06-09 Pending JPS4817267B1 (ja)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP45049666A JPS4817267B1 (ja) 1970-06-09 1970-06-09
US145468A US3867437A (en) 1970-06-09 1971-05-20 N-acyl-N{40 -substituted-2,6-diamino-benzoic acids and process for making the same
NL7107358A NL7107358A (ja) 1970-06-09 1971-05-28
SE07336/71A SE366542B (ja) 1970-06-09 1971-06-07
GB1949271*[A GB1320484A (en) 1970-06-09 1971-06-08 2,6-diaminobenzoic acid derivatives
CH857671A CH555806A (de) 1970-06-09 1971-06-08 Verfahren zur herstellung von derivaten der 2,6-diaminobenzoesaeure.
DE2128381A DE2128381C3 (de) 1970-06-09 1971-06-08 N-Acyl-N'-substituierte-a.e-Diaminobenzosäurederivate und Verfahren zu ihrer Herstellung
FR7120913A FR2095112A5 (ja) 1970-06-09 1971-06-09
BE768276A BE768276A (fr) 1970-06-09 1971-06-09 Acides n-acyl-n'-substitue-2,6-diaminobenzoiques et leur preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP45049666A JPS4817267B1 (ja) 1970-06-09 1970-06-09
FR7120913A FR2095112A5 (ja) 1970-06-09 1971-06-09

Publications (1)

Publication Number Publication Date
JPS4817267B1 true JPS4817267B1 (ja) 1973-05-28

Family

ID=26216441

Family Applications (1)

Application Number Title Priority Date Filing Date
JP45049666A Pending JPS4817267B1 (ja) 1970-06-09 1970-06-09

Country Status (9)

Country Link
US (1) US3867437A (ja)
JP (1) JPS4817267B1 (ja)
BE (1) BE768276A (ja)
CH (1) CH555806A (ja)
DE (1) DE2128381C3 (ja)
FR (1) FR2095112A5 (ja)
GB (1) GB1320484A (ja)
NL (1) NL7107358A (ja)
SE (1) SE366542B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010526788A (ja) * 2007-05-11 2010-08-05 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 過剰増殖性疾患およびマイトジェン細胞外キナーゼ活性関連性疾患を治療するための置換フェニルアミノ−ベンゼン誘導体

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0660145B2 (ja) * 1989-02-09 1994-08-10 東洋紡績株式会社 新規置換アセトアミド化合物
US5183891A (en) * 1989-11-09 1993-02-02 Orsan Method for the preparation of substituted 1,4-dihydro-4-oxo-cinnoline-3-carboxylic acid, esters and salts thereof, and intermediates used in their preparation
AU2003258491A1 (en) * 2002-09-05 2004-03-29 Neurosearch A/S Amide derivatives and their use as chloride channel blockers
JP5667044B2 (ja) * 2008-04-22 2015-02-12 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 置換されたフェノキシベンズアミド
JP2013508318A (ja) * 2009-10-21 2013-03-07 バイエル・ファルマ・アクチェンゲゼルシャフト 置換されたベンゾスルホンアミド誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413313A (en) * 1964-06-18 1968-11-26 Parke Davis & Co Anthranilic acid compounds and methods for their production

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010526788A (ja) * 2007-05-11 2010-08-05 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 過剰増殖性疾患およびマイトジェン細胞外キナーゼ活性関連性疾患を治療するための置換フェニルアミノ−ベンゼン誘導体

Also Published As

Publication number Publication date
SE366542B (ja) 1974-04-29
GB1320484A (en) 1973-06-13
DE2128381C3 (de) 1979-11-29
FR2095112A5 (ja) 1972-02-04
DE2128381A1 (de) 1971-12-16
CH555806A (de) 1974-11-15
DE2128381B2 (de) 1979-04-05
BE768276A (fr) 1971-11-03
NL7107358A (ja) 1971-12-13
US3867437A (en) 1975-02-18

Similar Documents

Publication Publication Date Title
AR204384A1 (ja)
FR2095112A5 (ja)
ATA96471A (ja)
AU2044470A (ja)
AU2085370A (ja)
AU2017870A (ja)
AU2130570A (ja)
AU1716970A (ja)
AU1833270A (ja)
AR195465A1 (ja)
AU1943370A (ja)
AU1832970A (ja)
AU1872870A (ja)
AU1879170A (ja)
AU1881070A (ja)
AU1581370A (ja)
AU1918570A (ja)
ATA672271A (ja)
AU1969370A (ja)
AU1974970A (ja)
AU1841070A (ja)
AU1591370A (ja)
AU2061170A (ja)
AU2115870A (ja)
AU2112570A (ja)